65,437 trials
Myelodysplastic Syndromes
Primary: Participants Who Achieved Red Blood Cell (RBC) Transfusion Independence for >= 26 Weeks (182 Days) — 3; 20; 23 Participants — p=<0.001
Relapsing-remitting Multiple Sclerosis
Primary: Estimated Annualized Aggregate Relapse Rate (ARR) — 0.16; 0.18; 0.40 Relapses per year
Malaria · Falciparum
Primary: Percentage of Participants With Auditory Abnormalities at Day 7 Assessed by Auditory Brainstem Response (ABR) Wave III Latency Changes on Day 7(a Type of Hearing Test)…
Genital Herpes
Primary: Investigator Assessed Time to Healing of All Non-aborted Genital Herpes Lesions — 5.38; 4.79 Days — p=0.4161
Attention-Deficit/Hyperactivity Disorder (ADHD)
Primary: Change From Pre-dose in the Swanson, Kotkin, Agler, M Flynn, and Pelham (SKAMP) Combined Attention and Deportment Scores at 10, 11, and 12 Hour (Averaged) Post-dose…
Infections, Rotavirus
Primary: Number of Subjects Reporting Grade 2 or 3 Symptoms (Fever, Vomiting or Diarrhoea) — 42 subjects
Influenza
Primary: Number of Seroconverted Subjects After the Second Dose of Pandemrix and After Vaccination With Fluarix — 79; 82; 40; 22 subjects
Age Related Macular Degeneration
Primary: Mean Change From Baseline in Best-corrected Visual Acuity of the Study Eye at Month 12 — 4.9; 3.8; 8.3 letters
Attention Deficit Disorder With Hyperactivity
Primary: Post-treatment ADHD Symptoms — 14.46; 19.19 units on a scale of symptom severity — p=<.03
Myeloid Leukemia, Chronic
Primary: Number of Participants With Best Confirmed Complete Cytogenetic Response (cCCyR) Within 12 Months — 204; 177 Participants — p=0.0056
Diabetes Mellitus, Type 2
Primary: Number of Participants With an Adverse Event — 110 participants
Parkinson's Disease With End of Dose Wearing Off
Primary: Change in Unified Parkinson's Disease Rating Scale (UPDRS) Part III Score From Baseline to Week 4 — -3.7; -1.8 Units on a scale
Depression
Primary: Remission — 58; 45 Percentage of participants — p=0.14
Breast Cancer · Metastasis
Primary: Number of Participants With Complete Response (CR) or Partial Response (PR) — 2; 0 participants
Pregnancy - Labor Monitoring
Primary: Comparison of SureCALL® and TOCO Detection of Contraction Events, as Compared to the IUPC, as Identified by Readers — 1.47; 0.85 Odds Ratio — p=0.0093